Differences in breast cancer hormone receptor status in ethnic groups: A London population

European Journal of Cancer

Volumn 49, Issue 3, 2013, Pages 696-702

  Jack, Ruth H ^a   Davies, Elizabeth A ^a   Renshaw, Christine ^a   Tutt, Andrew ^b   Grocock, Melanie J ^a   Coupland, Victoria H ^a   Møller, Henrik ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Ethnic groups; Survival; Triple negative breast cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; ASIAN; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; ETHNIC GROUP; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEGRO; PRIORITY JOURNAL; SOCIAL STATUS; TRIPLE NEGATIVE BREAST CANCER; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GREAT BRITAIN; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 84872679215     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.09.012     Document Type: Article

References (29)

1. Office for National Statistics Cancer statistics registrations. Registrations of cancer diagnosed in 2009 2011 Office for National Statistics London
2. E.A. Rakha, D.A. El-Rehim, and C. Paish Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance Eur J Cancer 42 2006 3149 3156
3. S. Cleator, W. Heller, and R.C. Coombes Triple-negative breast cancer: therapeutic options Lancet Oncol 8 2007 235 244
4. A. Goldhirsch, W.C. Wood, A.S. Coates, R.D. Gelber, B. Thurlimann, and H.J. Senn Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Ann Oncol 22 2011 1736 1747
5. C.A. Parise, K.R. Bauer, M.M. Brown, and V. Caggiano Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004 Breast J 15 2009 593 602
6. W.J. Irvin Jr., and L.A. Carey What is triple-negative breast cancer? Eur J Cancer 44 2008 2799 2805
7. R. Dent, M. Trudeau, and K.I. Pritchard Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 13 2007 4429 4434
8. K.R. Bauer, M. Brown, R.D. Cress, C.A. Parise, and V. Caggiano Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry Cancer 109 2007 1721 1728
9. L.A. Stead, T.L. Lash, and J.E. Sobieraj Triple-negative breast cancers are increased in black women regardless of age or body mass index Breast Cancer Res 11 2009 R18
10. M.J. Lund, E.N. Butler, and B.Y. Hair Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes: a population-based study and first report Cancer 116 2010 2549 2559
11. K.C. Amirikia, P. Mills, J. Bush, and L.A. Newman Higher population-based incidence rates of triple-negative breast cancer among young African-American women: implications for breast cancer screening recommendations Cancer 117 2011 2747 2753
12. R.L. Bowen, S.W. Duffy, D.A. Ryan, I.R. Hart, and J.L. Jones Early onset of breast cancer in a group of British black women Br J Cancer 98 2008 277 281
13. A.D. Deshpande, D.B. Jeffe, J. Gnerlich, A.Z. Iqbal, A. Thummalakunta, and J.A. Margenthaler Racial disparities in breast cancer survival: an analysis by age and stage J Surg Res 153 2009 105 113
14. V. Grann, A.B. Troxel, N. Zojwalla, D. Hershman, S.A. Glied, and J.S. Jacobson Regional and racial disparities in breast cancer-specific mortality Soc Sci Med 62 2006 337 347
15. C. Smigal, A. Jemal, and E. Ward Trends in breast cancer by race and ethnicity: update 2006 CA Cancer J Clin 56 2006 168 183
16. S. Farooq, and M.P. Coleman Breast cancer survival in South Asian women in England and Wales J Epidemiol Community Health 59 2005 402 406
17. R.H. Jack, E.A. Davies, and H. Møller Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England Br J Cancer 100 2009 545 550
18. R.H. Jack, E.A. Davies, and H. Møller Breast cancer and age in Black and White women in South East England Int J Cancer 30 2012 1227 1229
19. M. Arnedos, A. Nerurkar, P. Osin, R. A'Hern, I.E. Smith, and M. Dowsett Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC) Ann Oncol 20 2009 1948 1952
20. M. Noble, D. McLennan, K. Wilkinson, A. Whitworth, H. Barnes, and C. Dibben The English indices of deprivation 2007 2008 Department for Communities and Local Government London
21. M.L. Telli, E.T. Chang, and A.W. Kurian Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry Breast Cancer Res Treat 127 2011 471 478
22. M. Ambroise, M. Ghosh, V.S. Mallikarjuna, and A. Kurian Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India Asian Pac J Cancer Prev 12 2011 625 629
23. J. Ghosh, S. Gupta, and S. Desai Estrogen, progesterone and HER2 receptor expression in breast tumors of patients, and their usage of HER2-targeted therapy, in a tertiary care centre in India Indian J Cancer 48 2011 391 396
24. A.A. Andaya, L. Enewold, M.J. Horner, I. Jatoi, C.D. Shriver, and K. Zhu Socioeconomic disparities and breast cancer hormone receptor status Cancer Causes Control 23 2012 951 958
25. N.H. Gordon Association of education and income with estrogen receptor status in primary breast cancer Am J Epidemiol 142 1995 796 803
26. N. Krieger, J.T. Chen, J.H. Ware, and A. Kaddour Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions Cancer Causes Control 19 2008 1305 1318
27. E.A. Rakha, M.E. El-Sayed, A.R. Green, A.H. Lee, J.F. Robertson, and I.O. Ellis Prognostic markers in triple-negative breast cancer Cancer 109 2007 25 32
28. National Cancer Intelligence Network. Cancer incidence and survival by major ethnic group in England, 2002-2006; 2009.
29. S.M. Moss, H. Cuckle, A. Evans, L. Johns, M. Waller, and L. Bobrow Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial Lancet 368 2006 2053 2060